e-Posters

Authors


BARANISHYNA HANNA
CHARVALOS EKATHERINA
EL MUBARAK MOHAMED
GIAGKOU EIRINI
GOLDENSON NICHOLAS
KOSTELLI GAVRIELLA
LAGOUMINTZIS GEORGE
PARADIS PIERRE EMMANUEL
PRAKASH SHIVAANI
SCIUSCIO DAVIDE
SHIFFMAN SAUL
WEIL ROXANA
ZAGORITI ZOI

#4

1- Epidemiology & Social Issues
SMOKING HABITS IN PATIENTS WITH ACUTE CORONARY SYNDROME, AFTER THEIR DISCHARGE FROM THE HOSPITAL

KOSTELLI GAVRIELLA

#5

2 - Toxicology and aerosol chemistry
TOXICOLOGICAL ASSESSMENT OF FLAVORED E-LIQUIDS IN SPRAGUE DAWLEY RATS IN AN OECD SUBCHRONIC INHALATION STUDY COMPLEMENTED BY SYSTEMS TOXICOLOGY ENDPOINTS

SCIUSCIO DAVIDE

#6

2 - Toxicology and aerosol chemistry
COMPARATIVE HEALTH RISK ASSESSMENT OF JUUL SYSTEM AND COMBUSTIBLE CIGARETTE

WEIL ROXANA

#7

2 - Toxicology and aerosol chemistry
REAL-TIME ASSESSMENT OF E-CIGARETTES AND CONVENTIONAL CIGARETTES EMISSIONS: AEROSOL SIZE DISTRIBUTIONS, MASS, AND NUMBER CONCENTRATIONS

LAGOUMINTZIS GEORGE

#8

2 - Toxicology and aerosol chemistry
EVALUATING THE IMPACT OF ELECTRONIC CIGARETTE FLAVORING AGENTS IN ALDEHYDE EMISSIONS

EL MUBARAK MOHAMED

#9

2 - Toxicology and aerosol chemistry
ALDEHYDE EMISSIONS IN RELATION WITH RESISTANCE TEMPERATURE AND AGING IN E-CIGARETTES

EL MUBARAK MOHAMED

#10

3 - Biomarkers’ evaluation in animal or human studies
THE ROLE OF ENDOTHELICAL GLYCOCALYX IN SMOKERS WITH ACUTE CORONARY SYNDROME

KOSTELLI GAVRIELLA

#13

4 - Preclinical evaluation
TOBACCO CIGARETTE, BUT NOT ELECTRONIC CIGARETTE AND HEATED TOBACCO PRODUCT, IMPAIRS 3T3-L1 PRE-ADIPOCYTE DIFFERENTIATION TO BEIGE ADIPOCYTES

ZAGORITI ZOI

#14

4 - Preclinical evaluation
COMPARATIVE ANALYSIS OF NICOTINE AND COTININE LEVELS BY LC-MS/MS IN MOUSE PLASMA AND BRAIN FOLLOWING EXPOSURE TO CIGARETTE SMOKE, HEATED TOBACCO PRODUCT AEROSOL AND E-CIG VAPOR

EL MUBARAK MOHAMED

#15

5 - Regulatory issues
THE IMPACT OF BANNING ENDS PRODUCTS ON COMBUSTIBLE CIGARETTE SALES: INITIAL EVIDENCE FROM U.S. STATE-LEVEL POLICIES

PRAKASH SHIVAANI

#17

6 - Smoking cessation
SWITCHING AMONG ADULT SMOKERS WHO PURCHASED THE JUUL SYSTEM: 12-MONTH FOLLOW-UP RESULTS FROM TWO LARGE LONGITUDINAL STUDIES

GOLDENSON NICHOLAS

#18

6 - Smoking cessation
MODELING POTENTIAL HEALTH GAINS AND HEALTH SYSTEM SAVINGS ASSOCIATED WITH VAPORIZED NICOTINE PRODUCTS IN CANADA

PARADIS PIERRE EMMANUEL

#19

6 - Smoking cessation
HELP HER QUIT: A WOMEN-CENTERED STRATEGY FOR UP-SKILLING OBGYNS IN TOBACCO HARMFULNESS KNOWLEDGE AND SMOKING CESSATION

CHARVALOS EKATHERINA

#23

7 - Clinical Assessment and Harm Reduction
NICOTINE PHARMACOKINETIC AND SUBJECTIVE ASSESSMENT OF THE JUUL SYSTEM WITH THREE NICOTINE CONCENTRATIONS RELATIVE TO COMBUSTIBLE CIGARETTES IN ADULT SMOKERS

GOLDENSON NICHOLAS

#24

7 - Clinical Assessment and Harm Reduction
ANALYSIS OF THE LUNG OVERALL CONDITION IN SMOKERS AND VOLUNTEERS, THAT USE ALTERNATIVE NICOTINE DELIVERY PRODUCTS

BARANISHYNA HANNA

#25

7 - Clinical Assessment and Harm Reduction
DIFFERENCES IN RATES OF ADULT SMOKERS SWITCHING AWAY FROM SMOKING USING JUUL SYSTEM PRODUCTS, ACROSS JURISDICTIONS WITH DIFFERENT MAXIMUM NICOTINE CONCENTRATIONS (NORTH AMERICA AND THE UNITED KINGDOM)

SHIFFMAN SAUL

#26

7 - Clinical Assessment and Harm Reduction
SMOKING AND MULITPLE SCLEROSIS (MS): EFFECT ON DISEASE DEVELOPMENT AND DISABILITY PROGRESSION

GIAGKOU EIRINI

#27

7 - Clinical Assessment and Harm Reduction
DEPENDENCE ON JUUL SYSTEM ENDS IS LOWER THAN CIGARETTE DEPENDENCE: ADULTS AND YOUTH

SHIFFMAN SAUL